Skip to content
Unrated Drug recall · FDA · Published April 23, 2026

JB Chemicals recalls Enalapril tablets due to impurities in organic tests

JB Chemicals recalls 20mg Enalapril Maleate tablets with impurities found in organic tests. This prescription medication was manufactured in India and distributed in the US. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-0520-2026DrugJB Chemicals ›
Take action

Contact the company

Recalling firmJB Chemicals and Pharmaceuticals LtdNeelam Centre A Wing A B Wing, 4th Floor; Hind Cycle Road · Mumbai, India
✎ GovInfoNow plain-language explainer

JB Chemicals has recalled 20 mg Enalapril Maleate tablets that failed organic impurities tests. This means the medication may contain harmful substances that could affect your health if taken. Read more at govinfonow.com/recall/31338-jb-chemicals-recalls-enalapril-tablets-due-to-impurities-in-organic.

Source Summary by GovInfoNow · govinfonow.com/recall/31338-jb-chemicals-recalls-enalapril-tablets-due-to-impurities-in-organic · Updated August 17, 2026 · FDA enforcement record: FDA #D-0520-2026

Cite this page

“JB Chemicals recalls Enalapril tablets due to impurities in organic tests.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31338-jb-chemicals-recalls-enalapril-tablets-due-to-impurities-in-organic. Based on FDA recall #D-0520-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0520-2026%22&limit=1).

The FDA announced on April 23, 2026, that JB Chemicals and Pharmaceuticals Ltd is recalling Enalapril Maleate Tablets, USP, 20 mg, due to failed impurity specifications. The recall affects 675 bottles distributed nationwide.

How to tell if you have it

  • Brand: JB Chemicals
  • Product: Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle
  • Manufacturer: Unique Pharmaceutical Laboratories
  • Distributor: Rising Pharma Holdings, Inc.
  • NDC: 64980-688-10
  • Lot #: GEH25023
  • Expiration Date: 6/30/2027
  • Quantity: 675 bottles

The hazard

The recall is due to out-of-specification results in the Organic Impurities Test for Enalapril Maleate Tablets. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show JB Chemicals and Pharmaceuticals Ltd has two other recalls on record since September 12, 2025. On June 24, 2026, the brand recalled Cetirizine Tablets due to cross-contamination with Ranitidine. Other recent recalls of similar products include Sagent Busulfan Injection Recall (May 4, 2026), Ajanta Pharma Fluphenazine Tablets Recall (August 25, 2026), and Macleods Olanzapine Tablets 5mg Recall (August 27, 2026).

How to tell if you have this one

Check for the 20 mg Enalapril Maleate tablets in a 1,000-count bottle with NDC 64980-688-10. The lot number GEH25023 was manufactured in Mumbai, India and expires June 30, 2027.

  • Brand
    JB Chemicals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Details

    Look for the NDC 64980-688-10 label on the bottle to confirm if it's the recalled product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 20 days after the firm started it.

1. Firm started the recall: Apr 23, 202612. FDA classified it Class II: May 5, 202623. Published in FDA’s Enforcement Report: May 13, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other JB Chemicals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0520-2026 (April 23, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0520-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA